Abstract
Introduction: The authors discuss a novel patient controlled analgesia system utilizing a preprogrammed device that delivers a small submucosal tablet of sufentanil.Areas covered: This submucosal sufentanil system is not yet commercially available. A literature review of the current patient controlled analgesia systems and current information of this device are discussed.Expert opinion: This novel device has the potential to enhance patient safety as it is preprogrammed and delivers a standard dose of sufentanil, a rapidly acting opioid devoid of active metabolites.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 845-851 |
| Number of pages | 7 |
| Journal | Expert Opinion on Drug Delivery |
| Volume | 12 |
| Issue number | 5 |
| DOIs | |
| State | Published - May 1 2015 |
Keywords
- Microtablet
- Pain
- Sublingual
- Sufentanil
ASJC Scopus subject areas
- Pharmaceutical Science
Fingerprint Dive into the research topics of 'The role of sublingual sufentanil nanotabs for pain relief'. Together they form a unique fingerprint.
Cite this
Minkowitz, H. S., & Candiotti, K. A. (2015). The role of sublingual sufentanil nanotabs for pain relief. Expert Opinion on Drug Delivery, 12(5), 845-851. https://doi.org/10.1517/17425247.2015.975202